Shih W J, Turturro F, Stipp V, DeSimone P
Nuclear Medicine Service, VAMC, Lexington, KY 40511, USA.
Ann Nucl Med. 1996 Nov;10(4):425-8. doi: 10.1007/BF03164804.
Tc-99m MIBI is taken up avidly by viable tumor tissue and does not accumulate in the necrotic carcinoma. We present a patient who underwent Tc-99m MIBI and Tc-99m HMDP thoracic SPECTs: a large area of increased MIBI uptake with central photopenia (ring appearance) in the right upper lung localizes bone imaging agent and does not localize multiple areas of intense uptake in the metastatic hilar mediastinum lymph nodes. Rapid growth of tumor cells in the lung leading to central necrosis/ischemia accounts for bone imaging agent localization in the tumor, as well as the ring-appearance of lung mass on Tc-99m MIBI imaging. These findings may reflect less viability of the lung tumor as compared with intense MIBI uptake in hilar/mediastinal lymph node uptake without bone agent localization.
锝-99m甲氧基异丁基异腈(Tc-99m MIBI)能被存活的肿瘤组织大量摄取,而不会在坏死的癌组织中积聚。我们报告一例接受了Tc-99m MIBI和Tc-99m亚甲基二膦酸盐(HMDP)胸部单光子发射计算机断层扫描(SPECT)的患者:右上肺出现一大片MIBI摄取增加区域,中央放射性稀疏(环形表现),该区域摄取骨显像剂,而转移性肺门纵隔淋巴结内多个摄取强烈的区域未摄取骨显像剂。肺内肿瘤细胞的快速生长导致中央坏死/缺血,这解释了骨显像剂在肿瘤内的定位,以及Tc-99m MIBI显像时肺肿块的环形表现。与肺门/纵隔淋巴结摄取MIBI强烈但无骨显像剂定位相比,这些发现可能反映出肺肿瘤的活性较低。